All News

Chronic obstructive pulmonary disease (COPD) patients may face various exacerbations that may affect their daily live with the disease through symptoms.

We talk to 5 more pharmacists with exciting side hustles

Interview well, get an offer, and end the employment intermission.

How can you engage patients to adapt healthy behaviors and be adherent? Motivational Interviewing may be the missing piece.

Learn why pharmacists are in a great position to join the fastest-growing area in health care: technology

Looking to differentiate your pharmacy? These easy strategies can help your patients and increase rapport and retention.

FDA officials have approved pegvaliase-pqpz (Palynziq, BioMarin Pharmaceutical) for adults with a rare and serious genetic disease, phenylketonuria (PKU).

A new study has found that patients with chronic obstructive pulmonary disease (COPD) better manage proper inhaler use with 1 branded single-use device than others.

Patients with relapsed/refractory B-cell acute lymphoblastic leukemia (ALL) who were treated with inotuzumab ozogamicin (InO) indicated better quality of life, functioning, and symptom scores compared with patients receiving standard-of-care chemotherapies.

Top news of the week from The American Journal of Pharmacy Benefits.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Researchers have identified a gene associated with the body’s circadian rhythm that may play a role in the development of breast cancer.

Novel enzyme therapy for adults with PKU, a rare genetic disease, has won approval from the agency.

We spend much of our time talking about work-life balance, and chasing after it, but such a balance is not possible.

Two studies assessed prostate specific antigen (PSA) progression in patients treated with apalutamide (Erleada, Janssen) and the association between PSA doubling time and survival.

Researchers compared lung cancer care and outcomes, including patient characteristics, stage of cancer at diagnosis, treatment, and overall survival of patients in the United States and England.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

A first-of-its-kind study found that mortality in the first year after critical illness is higher among older adults with Medicaid insurance compared to those with Medicare and additional commercial insurance, especially among those discharged to skilled-care facilities.

Brain damage can begin early in infection, particularly during untreated infection, and can cause cognitive impairment.

The FDA is taking new steps to ensure products being marketed to protect consumers from the sun’s harmful effects deliver on their promises, starting with warning letters sent to companies marketing products with unproven claims.

The FDA has approved an updated label for Eli Lilly’s ixekizumab (Taltz) injection 80 mg/mL to include data in psoriasis involving the genital area.

The FDA is taking new steps to ensure products being marketed to protect consumers from the sun’s harmful effects deliver on their promises, as it recognizes No Fry Day.

The FDA has issued a warning to patients to avoid using OTC benzocaine teething products due to the risk of a dangerous condition, methemoglobinemia.

Critical care pharmacists ensure optimal pharmaceutical care in critically ill patients.

Ixekizumab (Taltz, Eli Lilly) is the first and only treatment approved by the FDA for moderate-to-severe plaque psoriasis that includes data on psoriasis involving the genital area in its label.

Data from two phase 3 studies found that emicizumab-kxwh (Hemlibra) prophylaxis controlled bleeds in patients with hemophilia A.

Antibiotics may worsen the care of some adult patients hospitalized with asthma exacerbations.